Why aspirin helps hearts of some and not others
Researchers including an Indian origin have shed some light on why aspirin benefits some people and not others.
Researchers at Duke Medicine developed a blood-based test of gene activity that has been shown to accurately identify who will respond to the therapy.
The study showed that the new gene expression profile not only measures the effectiveness of aspirin, but also serves as a strong predictor of patients who are at risk for heart attack.